BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10587587)

  • 1. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance.
    Takeda K; Takemoto C; Kobayashi I; Watanabe A; Nobukuni Y; Fisher DE; Tachibana M
    Hum Mol Genet; 2000 Jan; 9(1):125-32. PubMed ID: 10587587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A.
    Tachibana M
    Pigment Cell Res; 1997; 10(1-2):25-33. PubMed ID: 9170159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A.
    Nobukuni Y; Watanabe A; Takeda K; Skarka H; Tachibana M
    Am J Hum Genet; 1996 Jul; 59(1):76-83. PubMed ID: 8659547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
    Watanabe A; Takeda K; Ploplis B; Tachibana M
    Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dominant negative mutant of microphthalmia transcription factor (MITF) lacking two transactivation domains suppresses transcription mediated by wild type MITF and a hyperactive MITF derivative.
    Vachtenheim J; Drdová B
    Pigment Cell Res; 2004 Feb; 17(1):43-50. PubMed ID: 14717844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis.
    Khaled M; Larribere L; Bille K; Aberdam E; Ortonne JP; Ballotti R; Bertolotto C
    J Biol Chem; 2002 Sep; 277(37):33690-7. PubMed ID: 12093801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.
    Bondurand N; Pingault V; Goerich DE; Lemort N; Sock E; Le Caignec C; Wegner M; Goossens M
    Hum Mol Genet; 2000 Aug; 9(13):1907-17. PubMed ID: 10942418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse Microphthalmia protein.
    Yasumoto K; Mahalingam H; Suzuki H; Yoshizawa M; Yokoyama K
    J Biochem; 1995 Nov; 118(5):874-81. PubMed ID: 8749302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation at the anophthalmic white locus in Syrian hamsters: haploinsufficiency in the Mitf gene mimics human Waardenburg syndrome type 2.
    Hodgkinson CA; Nakayama A; Li H; Swenson LB; Opdecamp K; Asher JH; Arnheiter H; Glaser T
    Hum Mol Genet; 1998 Apr; 7(4):703-8. PubMed ID: 9499424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MITF: a stream flowing for pigment cells.
    Tachibana M
    Pigment Cell Res; 2000 Aug; 13(4):230-40. PubMed ID: 10952390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
    Fang D; Setaluri V
    Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the mutant microphthalmia-associated transcription factor found in Tietz syndrome on the in vitro development of mast cells.
    Shigemura T; Shiohara M; Tanaka M; Takeuchi K; Koike K
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):442-7. PubMed ID: 20485200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.
    Verastegui C; Bille K; Ortonne JP; Ballotti R
    J Biol Chem; 2000 Oct; 275(40):30757-60. PubMed ID: 10938265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.
    Yasumoto K; Yokoyama K; Shibata K; Tomita Y; Shibahara S
    Mol Cell Biol; 1994 Dec; 14(12):8058-70. PubMed ID: 7969144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutation screening of MITF gene in patients with Waardenburg syndrome type 2].
    Chen J; Yang SZ; Liu J; Han B; Wang GJ; Zhang X; Kang DY; Dai P; Young WY; Yuan HJ
    Yi Chuan; 2008 Apr; 30(4):433-8. PubMed ID: 18424413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
    Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
    Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytes and the microphthalmia transcription factor network.
    Steingrímsson E; Copeland NG; Jenkins NA
    Annu Rev Genet; 2004; 38():365-411. PubMed ID: 15568981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).
    Morell R; Spritz RA; Ho L; Pierpont J; Guo W; Friedman TB; Asher JH
    Hum Mol Genet; 1997 May; 6(5):659-64. PubMed ID: 9158138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of nuclear localization and signal function of MITF protein predisposing to Warrdenburg syndrome].
    Zhang H; Feng J; Chen H; Li J; Luo H; Feng Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):805-9. PubMed ID: 26663053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
    Fang D; Tsuji Y; Setaluri V
    Nucleic Acids Res; 2002 Jul; 30(14):3096-106. PubMed ID: 12136092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.